Skip to main content
Premium Trial:

Request an Annual Quote

Strand, India's MSCC Partner on Translation Cancer Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Informatics firm Strand Life Sciences announced on Wednesday it has signed a memorandum of understanding focused on translational cancer research with India's Mazumdar Shaw Comprehensive Cancer Centre of the Narayana Hrudalaya.

Specifically, the partnership includes joint research and training in translational cancer using genomics and proteomics.

The partners have begun a pilot project studying head and neck cancer, one of the most prevalent types of cancer in India, Strand said in a statement. According to Binay Panda, senior vice president of Strand and head of Ganit Labs — a state of the art functional genomics and next-generation sequencing center in Bangalore, India — the collaboration brings together for the first time in that country scientists from fields as diverse as computer science, head and neck surgery, and genome biology for comprehensive research work.

Strand, which has offices in Bangalore and San Francisco, is a participant in the public-private initiative to create Ganit Labs.

Terms of the deal were not disclosed.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.